Sheller in Bloomberg Business on Whistleblowers and J&J $2.2B Settlement

Bloomberg Business Week 2013-12-09 Judy Doetterl was a sales representative for Johnson & Johnson (JNJ) in 2004 when federal agents placed a hidden recording device on her and sent her to tape marketing presentations at a national company sales meeting. U.S. prosecutors wanted to prove claims by Doetterl and others that J&J boosted sales by urging doctors to prescribe […]

J&J to Pay at Least $2.5 Billion to Settle Hip Lawsuits

The Wall Street Journal 2013-11-19 The Wall Street Journal reports that Johnson & Johnson has agreed to pay at least $2.5 billion to settle nearly 8,000 hip implant lawsuits In its latest multibillion-dollar legal settlement, Johnson & Johnson has agreed to pay at least $2.5 billion to resolve thousands of lawsuits filed by patients who […]

Sheller in Chronicle of Higher Education on Major Drug Fraud

The Chronicle of Higher Education 2013-11-08 Federal prosecutors on Thursday concluded another multibillion-dollar settlement with a major pharmaceutical company accused of illegally marketing its drugs. In this case, the company was Johnson & Johnson, the total payment was $2.2-billion, and the key drug was Risperdal, which was approved by federal regulators to treat schizophrenia in […]

Sheller settles Whistleblower UMass medical billing fraud case for 66k

The Boston Globe 2013-08-22 Worcester’s UMass Memorial Medical Center has settled fraud charges with the attorney general in a whistleblower case alleging that it improperly sent bills for uninsured patients to a homeless shelter, so it could tap the state for payments. On dozens of occasions, the hospital sent unpaid bills for emergency care to […]

Number One in Pennsylvania for Verdicts and Settlements 2014

2014-12-19 The $2.2 Billion settlement with Johnson & Johnson Leads the Pack The Legal Intelligencer reported that the largest verdict and settlement award in Pennsylvania between August 2013 and August 2014 was handled by Sheller, P.C. with a $2.2 billion settlement over healthcare giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals.  J&J paid the […]

Sheller on American Law Journal TV discussing FDA and Pharma Executives,

The American Law Journal 2013-06-16 Attorney Stephen Sheller sparred with pharmaceutical defense attorney Hope Freiwald of Dechert law firm on the television program The American Law Journal. The attorneys, joined by Pharmalot author Ed Silverman, Atlanta pharmaceutical product liability attorney Matthew Harman in a program moderated by attorney Christopher Naughton discussed the FDA and drug […]

Sheller in Philadelphia Inquirer “High Court Sides with Philadelphia Drug Firm”

2013-06-25 In a case involving a Philadelphia company, a divided U.S. Supreme Court ruled Monday that federal pharmaceutical laws preempt a person’s ability to sue in state court alleging that a generic drug is designed badly and therefore is dangerous. The court’s 5-4 decision in Mutual Pharmaceutical Co. v. Bartlett is a victory for the […]

SuperLawyers 2013: seven Sheller, P.C. attorneys honored

2013-05-17  [pdf-embedder url=”http://sheller.com/wp-content/uploads/2013/05/Sheller_PASLRS13_FINAL.pdf”] The law firm of Sheller, P.C. announces the selection of six attorneys as Pennsylvania SuperLawyers® and one as Pennsylvania Rising Star for 2013. Stephen A. Sheller is once again honored for the tenth straight year, and for the fourth year as a Top 100 Philadelphia and Top 100 Pennsylvania SuperLawyers®. Also for […]

Temple Times on Sheller Center for Social Justice

2013-02-15   [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/Temple_Times_story_Sheller_Center_for_Social_Justice_2_15_13.pdf”] Featured story: “Sheller Family Foundation’s $1.5 million gift to Temple Law will establish Social Justice Center” Stephen and Sandra Sheller, who have spent their respective careers in law and behavioral health treatment advocating for the poor, powerless and those experiencing injustice, have made a $1.5 million gift to establish a new […]